相似文献
1
The tobacco industry, researchers, and ethical access to UK Biobank: using the public interest and public good.
Am J Public Health. 2014 Oct;104(10):1833-9. doi: 10.2105/AJPH.2014.302138. Epub 2014 Aug 14.
2
Is science public health's BFF?
Am J Public Health. 2014 Oct;104(10):1798. doi: 10.2105/AJPH.2014.302209. Epub 2014 Aug 14.
3
Conflicts of interest in e-cigarette research: A public good and public interest perspective.
Bioethics. 2020 Jan;34(1):114-122. doi: 10.1111/bioe.12619. Epub 2019 Aug 25.
4
Conflicts of interest in tobacco industry-funded research.
Lancet Oncol. 2021 Jun;22(6):758. doi: 10.1016/S1470-2045(21)00281-3. Epub 2021 May 6.
5
The advantages of UK Biobank's open-access strategy for health research.
J Intern Med. 2019 Oct;286(4):389-397. doi: 10.1111/joim.12955. Epub 2019 Aug 2.
6
Genetics, lifestyle and environment. UK Biobank is an open access resource following the lives of 500,000 participants to improve the health of future generations.
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2016 Mar;59(3):361-7. doi: 10.1007/s00103-015-2297-0.
7
Governing UK Biobank: the importance of ensuring public trust.
Trends Biotechnol. 2004 Jun;22(6):284-5. doi: 10.1016/j.tibtech.2004.04.007.
8
Models of biobanks and implications for reproductive health innovation.
Monash Bioeth Rev. 2015 Dec;33(4):238-57. doi: 10.1007/s40592-015-0042-y.
9
Relationship between the Chinese tobacco industry and academic institutions in China.
Tob Control. 2011 Jan;20(1):12-9. doi: 10.1136/tc.2010.036079. Epub 2010 Oct 15.
10
Should academic journals publish e-cigarette research linked to tobacco companies?
Addiction. 2016 Aug;111(8):1328-32. doi: 10.1111/add.13067. Epub 2015 Sep 28.
引用本文的文献
1
Consent and its discontents: the case of UK Biobank.
Med Health Care Philos. 2025 Sep;28(3):533-547. doi: 10.1007/s11019-025-10276-5. Epub 2025 Jul 17.
2
Can a good tree bring forth evil fruit? The funding of medical research by industry.
Br Med Bull. 2016 Jun;118(1):5-15. doi: 10.1093/bmb/ldw014. Epub 2016 May 5.
3
Models of biobanks and implications for reproductive health innovation.
Monash Bioeth Rev. 2015 Dec;33(4):238-57. doi: 10.1007/s40592-015-0042-y.
本文引用的文献
1
Changing Tobacco Control's policy on tobacco industry-funded research.
Tob Control. 2013 Jan;22(1):1-2. doi: 10.1136/tobaccocontrol-2012-050874.
2
New models for large prospective studies: is there a better way?
Am J Epidemiol. 2012 May 1;175(9):859-66. doi: 10.1093/aje/kwr453. Epub 2012 Mar 12.
3
'To prove this is the industry's best hope': big tobacco's support of research on the genetics of nicotine addiction.
Addiction. 2010 Jun;105(6):974-83. doi: 10.1111/j.1360-0443.2010.02940.x.
4
The "father of stress" meets "big tobacco": Hans Selye and the tobacco industry.
Am J Public Health. 2011 Mar;101(3):411-8. doi: 10.2105/AJPH.2009.177634. Epub 2010 May 13.
5
Tobacco industry sociological programs to influence public beliefs about smoking.
Soc Sci Med. 2008 Feb;66(4):970-81. doi: 10.1016/j.socscimed.2007.11.007.
6
Partnership in U.K. Biobank: a third way for genomic property?
J Law Med Ethics. 2007 Fall;35(3):440-56. doi: 10.1111/j.1748-720X.2007.00166.x.
7
Old ways, new means: tobacco industry funding of academic and private sector scientists since the Master Settlement Agreement.
Tob Control. 2007 Jun;16(3):157-64. doi: 10.1136/tc.2006.017186.
8
The ethics of research using biobanks: reason to question the importance attributed to informed consent.
Arch Intern Med. 2005 Jan 10;165(1):97-100. doi: 10.1001/archinte.165.1.97.
9
The smoke you don't see: uncovering tobacco industry scientific strategies aimed against environmental tobacco smoke policies.
Am J Public Health. 2001 Sep;91(9):1419-23. doi: 10.2105/ajph.91.9.1419.
10
Universities and tobacco money.
BMJ. 2001 Jul 7;323(7303):1-2. doi: 10.1136/bmj.323.7303.1.
Zotero 插件